This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Silvestre, J. S. Articles by Palacios, J. M. Search for Related Content PubMed PubMed Citation Articles by Silvestre, J. S. Articles by Palacios, J. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Anxiety Hazardous Substances DB DIAZEPAM IMIPRAMINE Social Bookmarking                         What's this?

Effects of rolipram on the elevated plus-maze test in rats: a preliminary study

Department of Pharmacology, Research Centre, Almirall-Prodesfarma, Cardener 68–74, Barcelona 08024, Spain; Prous Science, SA Provenca 388 Barcelona 08025 Spain silvest{at}autovia.com

Andrés G. Fernández

José M. Palacios

Department of Pharmacology, Research Centre, Almirall-Prodesfarma, Cardener 68–74, Barcelona 08024, Spain

The objective of the present study was to assess the behavioural effects of rolipram, a specific cAMP phosphodiesterase (PDE4) inhibitor, in the elevated plus-maze (EPM) test in rats. Results showed that rolipram at the highest dose tested (0.1mg/kg) increased the percentage of both time spent and entries into open arms, although a decrease of locomotor activity in the EPM test was also observed. In contrast, diazepam (3.0 mg/kg) exhibited the typical profile of an anxiolytic in the EPM test, increasing the percentage of time spent and entries into open arms as well as locomotor activity. A posterior statistical analysis, however, established that the effects of both rolipram and diazepam on parameters denoting anxiolytic-like activity were statistically independent from those reflecting locomotor activity reduction. Furthermore, the effects of both rolipram and diazepam were shown to be distinct from those exhibited by tryciclic antidepressant imipramine which did not show any anxiolytic-like effects in the EPM test, although a reduction of locomotor activity was also detected. Although these preliminary results suggest that rolipram may have some anxiolytic-like properties on the EPM test in rats, such an interpretation should be taken cautiously due to the observed effects on locomotor activity, which could complicate the interpretation of results from rolipram and other PDE4 inhibitors in the current test and in other anxiety animal models.

Key Words: anxiety • behaviour • diazepam • elevated plus-maze • imipramine • rat • rolipram

Journal of Psychopharmacology, Vol. 13, No. 3, 274-277 (1999)
DOI: 10.1177/026988119901300309


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				C. Favilla, T. Abel, and M. P. Kelly Chronic G{alpha}s Signaling in the Striatum Increases Anxiety-Related Behaviors Independent of Developmental Effects J. Neurosci., December 17, 2008; 28(51): 13952 - 13956. [Abstract] [Full Text] [PDF]

				H. Ashton, A. H. Young, and N. Ferrier Psychopharmacology revisited J Psychopharmacol, May 1, 1999; 13(3): 296 - 298. [PDF]